Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.


Abstract

In both models, VX-166 inhibited apoptosis and reduced histological inflammatory infiltrate although there was a more modest impact on other indices of liver injury.

In addition, TPGS/PEG vehicle also exhibited some anti-inflammatory activity, likely through the antioxidant effects of vitamin E and changes in gut flora/mucosal interactions.

These data suggest that caspase inhibition may represent a valid therapeutic approach; however, further studies to assess the long-term value of more selective caspase inhibition are merited.


Full Text


Subjects


Similar articles

Español | English

© Galenicom 1999-2013